SUI and POP are conditions that generally affect middle-aged women who have borne children. Given the size and breadth of the Baby Boom generation, the majority of whom are middle-aged and beginning to ease into retirement, the demographic represents a sizeable opportunity to any medical device manufacturer catering to the needs of this particular sector of the American population. AMS transvaginal mesh is such a product.
The AMS transvaginal mesh lawsuit was filed May 17 in US District Court for the Southern District of West Virginia (Case No. 2:13-cv-11742) in the multidistrict litigation (MDL) entitled In Re: American Medical Systems Inc., Pelvic Repair System Products Liability Litigation (MDL No. 2325).
According to court records, the plaintiff received the SPARC and IntePro LLP Y-Sling, manufactured and marketed by AMS mesh, two years prior to launching her AMS legal action. The plaintiff asserts that following implantation of the AMS tvm in May 2011 she suffered injury and alleges the device is defective. Akin to other lawsuits, the plaintiff in this case claims that the defendant, American Medical Systems, knew about the defects inherent with its devices but failed to warn consumers in an effort to shield and protect its own financial interests.
While AMS transvaginal mesh has been named in various AMS legal challenges, American Medical Systems is only one of 33 manufacturers mandated by the US Food and Drug Administration (FDA) to conduct post-market studies on their tvm mesh products. This, after a 2011 FDA caution that suggested complications involving mesh implants are “not rare” and may not be the safest method of treating POP and SUI.
READ MORE AMS TRANSVAGINAL MESH LEGAL NEWS
According to PRWeb Newswire (6/24/13), legal presentations toward the selection of five bellwether TVM mesh cases were made June 25. In the meantime, the future health and well-being of thousands of women across the US hang in the balance after having received TVM mesh - including AMS tvt (transvaginal tape, or transvaginal sling). Many of those women allege AMS transvaginal mesh injury.